EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing

San Hae Im, Mincheol Jang, Ji-Ho Park, Hyun Jung Chung

Journal of Nanobiotechnology · 12.04.2024 · 22 (1)

DOI: 10.1186/s12951-024-02427-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 12.04.2024. Verfasst von San Hae Im und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic o…. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Liposomes, Nanoparticles. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nonviral delivery of the CRISPR/Cas9 system provides great benefits for in vivo gene therapy due to the low risk of side effects. However, in vivo gene editing by delivering the Cas9 ribonucleoprotein (RNP) is challenging due to the poor delivery into target tissues and cells. Here, we introduce an effective delivery method for the CRISPR/Cas9 RNPs by finely tuning the formulation of ionizable lipid nanoparticles. The LNPs delivering CRISPR/Cas9 RNPs (CrLNPs) are demonstrated to induce gene editing with high efficiencies in various cancer cell lines in vitro. Furthermore, we show that CrLNPs can be delivered into tumor tissues with high efficiency, as well as induce significant gene editing in vivo. The current study presents an effective platform for nonviral delivery of the CRISPR/Cas9 system that can be applied as an in vivo gene editing therapeutic for treating various diseases such as cancer and genetic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsLiposomesNanoparticlesCell LineRibonucleoproteins

Stichwörter der Autor:innen

CRISPR/Cas9In vivo deliveryLipid nanoparticlesRibonucleoprotein

Substanzen

Lipid NanoparticlesRibonucleoproteinsLiposomes

Autor:innen und Institutionen

  • Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
  • Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
  • Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea. jihopark@kaist.ac.kr.
  • KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea. jihopark@kaist.ac.kr.
  • Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea. hyunjc@kaist.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Health and Welfare

Zitieren

APA

Im, S. H., Jang, M., Park, J. H., & Chung, H. J. (2024). Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02427-2

Vancouver

Im SH, Jang M, Park JH, Chung HJ. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02427-2

BibTeX
@article{Im2024,
  author = {Im, San Hae and Jang, Mincheol and Park, Ji-Ho and Chung, Hyun Jung},
  title = {Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12951-024-02427-2}
}
Kostenlos starten →